Skip to Main Content

Paper Details

Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 - 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study.
Int J Clin Pharmacol Ther
6
2014

Datasets

Release 1.2